Brand Name | Status | Last Update |
---|---|---|
aleve arthritis pain gel | ANDA | 2023-11-30 |
amazon basic care arthritis pain | ANDA | 2024-05-17 |
arthritis pain | ANDA | 2024-03-18 |
arthritis pain reliever | ANDA | 2024-06-14 |
arthritis pain relieving | ANDA | 2023-05-15 |
arthrotec | New Drug Application | 2023-08-16 |
aspercreme arthritis | ANDA | 2023-10-11 |
basic care arthritis pain | ANDA | 2022-01-06 |
bentyl | New Drug Application | 2024-04-03 |
berkley and jensen arthritis pain | ANDA | 2023-07-26 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
neuroblastoma | EFO_0000621 | D009447 | — |
hodgkin disease | — | D006689 | C81 |
melanoma | — | D008545 | — |
fibrosarcoma | — | D005354 | — |
rhabdomyosarcoma | — | D012208 | — |
islet cell carcinoma | — | D018273 | C25.4 |
medullary carcinoma | — | D018276 | — |
Code | Description |
---|---|
J9130 | Dacarbazine, 100 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Melanoma | D008545 | — | — | 20 | 57 | 36 | 1 | 3 | 102 |
Hodgkin disease | D006689 | — | C81 | 5 | 52 | 26 | 1 | 7 | 86 |
Lymphoma | D008223 | — | C85.9 | 5 | 50 | 26 | 1 | 7 | 84 |
Neoplasm metastasis | D009362 | EFO_0009708 | — | — | 3 | 2 | 1 | — | 5 |
Non-hodgkin lymphoma | D008228 | — | C85.9 | — | 1 | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Sarcoma | D012509 | — | — | 3 | 9 | 8 | — | 1 | 18 |
Leiomyosarcoma | D007890 | — | — | 1 | 4 | 5 | — | — | 9 |
Uveal neoplasms | D014604 | EFO_1001230 | — | — | 6 | 2 | — | — | 7 |
Neoplasms | D009369 | — | C80 | 3 | 3 | 1 | — | — | 6 |
Neuroblastoma | D009447 | EFO_0000621 | — | — | 1 | 4 | — | 1 | 6 |
Skin neoplasms | D012878 | EFO_0004198 | C44 | — | 3 | 3 | — | — | 5 |
Cutaneous malignant melanoma | D000096142 | — | — | — | 1 | 2 | — | — | 3 |
Liposarcoma | D008080 | — | — | — | — | 3 | — | — | 3 |
Sclerosis | D012598 | — | — | — | 1 | 1 | — | — | 2 |
T-cell lymphoma | D016399 | — | — | — | 1 | 1 | — | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Carcinoma | D002277 | — | C80.0 | 2 | 2 | — | — | — | 3 |
Neuroendocrine tumors | D018358 | EFO_1001901 | D3A.8 | — | 2 | — | — | 1 | 3 |
Immunotherapy | D007167 | — | — | 1 | 2 | — | — | — | 2 |
Osteosarcoma | D012516 | — | — | 1 | 2 | — | — | — | 2 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 2 | — | — | — | 2 |
Urologic neoplasms | D014571 | — | C64-C68 | — | 1 | — | — | — | 1 |
Urinary bladder neoplasms | D001749 | — | C67 | — | 1 | — | — | — | 1 |
Transitional cell carcinoma | D002295 | — | — | — | 1 | — | — | — | 1 |
Thyroid neoplasms | D013964 | EFO_0003841 | — | 1 | 1 | — | — | — | 1 |
Thyroid diseases | D013959 | HP_0000820 | E00-E07 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 2 | — | — | — | 1 | 3 |
Small cell carcinoma | D018288 | — | — | 1 | — | — | — | — | 1 |
Small cell lung carcinoma | D055752 | — | — | 1 | — | — | — | — | 1 |
Carcinoid tumor | D002276 | — | D3A.00 | 1 | — | — | — | — | 1 |
Parathyroid neoplasms | D010282 | — | — | 1 | — | — | — | — | 1 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | 1 | — | — | — | — | 1 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | 1 | — | — | — | — | 1 |
Colonic neoplasms | D003110 | — | C18 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | — | — | — | — | 1 | 1 |
Drug common name | Dacarbazine |
INN | dacarbazine |
Description | Dacarbazine is a monocarboxylic acid amide that is 1H-imidazole-4-carboxamide which is substituted at position 5 by a 3,3-dimethyltriaz-1-en-1-yl group. It is used for the treatment of metastatic malignant melanoma, and in combination with other drugs for the treatment of Hodgkin's disease and soft-tissue sarcoma. It has a role as an antineoplastic agent, an alkylating agent, a prodrug and a carcinogenic agent. It is a monocarboxylic acid amide, a member of imidazoles and a triazene derivative. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CN(C)/N=N/c1[nH]cnc1C(N)=O |
PDB | — |
CAS-ID | 1185241-28-4 |
RxCUI | — |
ChEMBL ID | CHEMBL476 |
ChEBI ID | — |
PubChem CID | 2942 |
DrugBank | DB00851 |
UNII ID | 7GR28W0FJI (ChemIDplus, GSRS) |